Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

GNW

Genworth Financial Inc

Feb 17 • 04:00PM ET

9.00

+0.08 0.90 %

Financial • Insurance - Life • USA • NYSE

Peers: HIG MET PRU LNC UNM CRBG RGA AIG AIZ VOYA

| Held by: IJR VTI IWM AVUV VB VBR VXF SPSM IJS IWN

Index	RUT	P/E	17.04	EPS (ttm)	0.53	Insider Own	2.15%	Shs Outstand	402.68M	Perf Week	1.35%
Market Cap	3.59B	Forward P/E	14.75	EPS next Y	0.61	Insider Trans	-1.90%	Shs Float	390.80M	Perf Month	8.43%
Enterprise Value	-	PEG	13.92	EPS next Q	0.16	Inst Own	86.51%	Short Float	2.11%	Perf Quarter	6.38%
Income	220.00M	P/S	0.51	EPS this Y	0.00%	Inst Trans	-1.15%	Short Ratio	2.11	Perf Half Y	8.04%
Sales	7.04B	P/B	0.41	EPS next Y	-1.61%	ROA	0.34%	Short Interest	8.26M	Perf YTD	-0.33%
Book/sh	21.88	P/C	-	EPS next 5Y	1.06%	ROE	2.86%	52W High	9.28 -3.02%	Perf Year	23.46%
Cash/sh	-	P/FCF	23.34	EPS past 3/5Y	-27.10% -5.65%	ROIC	2.13%	52W Low	5.99 50.25%	Perf 3Y	44.23%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.97% -2.44%	Gross Margin	-	Volatility	2.39% 2.40%	Perf 5Y	167.86%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	150.35%	Oper. Margin	8.14%	ATR (14)	0.21	Perf 10Y	366.32%
Dividend Ex-Date	Oct 08, 2008	Quick Ratio	-	Sales Y/Y TTM	1.41%	Profit Margin	3.13%	RSI (14)	59.36	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	43.95%	SMA20	4.67%	Beta	0.99	Target Price	10.00
Payout	0.00%	Debt/Eq	0.17	Sales Q/Q	0.27%	SMA50	2.53%	Rel Volume	0.70	Prev Close	8.92
Employees	2960	LT Debt/Eq	0.17	Earnings	Feb 23 AMC	SMA200	9.33%	Avg Volume	3.92M	Price	9.00
IPO	May 25, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-60.00% -	Trades		Volume	2,755,930	Change	0.90%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-18-25	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$9
Sep-23-16	Resumed	Wells Fargo	Market Perform
May-05-16	Reiterated	Compass Point	Buy	$5.50 → $5.25
Feb-08-16	Reiterated	Compass Point	Buy	$7.50 → $5.50
Nov-17-15	Initiated	Goldman	Neutral	$5
Nov-04-15	Downgrade	UBS	Neutral → Sell	$5.25 → $4.25
Sep-08-15	Reiterated	UBS	Neutral	$8.50 → $5.25
Aug-10-15	Reiterated	Compass Point	Buy	$12 → $7.50
Aug-06-15	Downgrade	Raymond James	Strong Buy → Outperform
Aug-05-15	Upgrade	Macquarie	Underperform → Neutral
Jul-20-15	Reiterated	UBS	Neutral	$10 → $8.50
May-28-15	Upgrade	Morgan Stanley	Underweight → Equal-Weight
May-07-15	Downgrade	Macquarie	Outperform → Underperform	$12 → $7
May-06-15	Reiterated	Jefferies	Buy	$10 → $12
May-05-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$8.50 → $8
Apr-30-15	Upgrade	Compass Point	Neutral → Buy
Nov-06-14	Downgrade	Compass Point	Buy → Neutral
Jul-31-14	Reiterated	Compass Point	Buy	$23 → $16.50
Mar-20-14	Reiterated	UBS	Buy	$18 → $20
Jan-07-14	Initiated	Compass Point	Buy	$22

Show Previous Ratings

Jan-20-26 10:00AM	CareScout Expands National Footprint with New Tools to Navigate Long-Term Care (Business Wire)
Jan-08-26 04:15PM	Genworth Financial Schedules Earnings Conference Call for February 24 (Business Wire)
Nov-06-25 04:20PM	Genworth Financial Inc (GNW) Q3 2025 Earnings Call Highlights: Strategic Moves and Challenges ... (GuruFocus.com)
Nov-05-25 05:31PM	Genworth Financial: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Genworth Financial Announces Third Quarter 2025 Results (Business Wire)
08:50AM	Loading…
Oct-22-25 08:50AM	Genworth Issues Statement on UK Court Approval of Santander Appeal Request (Business Wire)
Oct-09-25 04:15PM	Genworth Financial Schedules Earnings Conference Call for November 6 (Business Wire)
Oct-01-25 09:00AM	CareScout Launches Care Assurance, First Insurance Solution for Company (Business Wire)
Sep-22-25 10:20AM	This Under-Followed Financial Stock Just Hit a 10-Year High (Barchart)
Sep-18-25 04:16PM	Genworth Financial Announces New $350 Million Share Repurchase Authorization (Business Wire)
Sep-08-25 11:00AM	How to save for retirement when youre in your 50s (Bankrate)
Aug-06-25 06:07PM	Genworth Financial Receives Ratings Upgrade from Moodys (Business Wire)
Aug-01-25 07:01PM	Genworth Financial Inc (GNW) Q2 2025 Earnings Call Highlights: Strong Operating Income and ... (GuruFocus.com)
Jul-30-25 05:07PM	Genworth Financial: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	Genworth Financial Announces Second Quarter 2025 Results (Business Wire)
11:04AM	Loading…
Jul-26-25 11:04AM	Genworth (GNW) Surges 9% as Firm Expects $750-Million Additional Cash (Insider Monkey)
Jul-25-25 09:35AM	Genworth Issues Statement on Favorable Ruling for AXA in UK Payment Protection Insurance Case (Business Wire) +8.99%
Jul-17-25 02:46AM	Genworth Financial (GNW)'s Net Investment Gains Help Net Income in Q1 2025 (Insider Monkey)
Jul-16-25 08:00AM	WTWs ICT appoints new Head of Personal and Commercial Lines Business Development in North America (GlobeNewswire)
Jul-10-25 04:15PM	Genworth Financial Schedules Earnings Conference Call for July 31 (Business Wire)
Jun-19-25 02:02PM	Genworth (GNW) Jumps 13.74% on Outperform Rating (Insider Monkey)
09:45AM	SanDisk initiated, Analog Devices upgraded: Wall Streets top analyst calls (TipRanks)
May-22-25 01:32PM	Genworth Financial Announces Results of Annual Meeting (Business Wire)
May-02-25 03:13AM	Genworth Financial Inc (GNW) Q1 2025 Earnings Call Highlights: Navigating Profitability Amidst ... (GuruFocus.com)
May-01-25 12:47PM	Genworth Financial, Inc. (GNW) Q1 2025 Earnings Call Transcript (Seeking Alpha)
Apr-30-25 05:06PM	Genworth Financial: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Genworth Financial Announces First Quarter 2025 Results (Business Wire)
Apr-28-25 06:20AM	Should You Invest in the SPDR S&P Insurance ETF (KIE)? (Zacks)
Apr-10-25 04:15PM	Genworth Financial Schedules Earnings Conference Call for May 1 (Business Wire)
Apr-08-25 12:42PM	Genworth Financial taps Capital One veteran for CIO role (CIO Dive)
11:30AM	Loading…
Apr-07-25 11:30AM	Genworth Names Morris Taylor Chief Information Officer (Business Wire) -5.38%
Apr-03-25 10:00AM	CareScout Partners with Dr. Judy Benjamin on Her Walk Across America (Business Wire)
Mar-28-25 02:54PM	This Is a Test From GlobeNewswire (GlobeNewswire)
Mar-25-25 11:11AM	Genworth Financial, Inc. (GNW): A Bull Case Theory (InsiderMonkey)
Mar-20-25 01:12PM	Value or Growth? SA spotlights 10 stocks that offer both (SeekingAlpha)
Mar-19-25 04:15PM	Genworth Financial Announces Election of Steven Van Wyk to Board of Directors (Business Wire)
Mar-04-25 11:00AM	Long-Term Care Costs Increase in Wisconsin, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in West Virginia, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Washington, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Washington DC, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Vermont, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Utah, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Texas, Remain Lower Than National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Tennessee, On Par With National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in South Dakota, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in South Carolina, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Rhode Island, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Pennsylvania, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Oregon, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Ohio, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in North Dakota, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in North Carolina, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in New York, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in New Mexico, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in New Jersey, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in New Hampshire, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Nevada, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Nebraska, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Montana, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Missouri, Remain Lower Than National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Mississippi, Remain Lower Than National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Minnesota, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Michigan, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Massachusetts, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Maryland, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Maine, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Louisiana, Remain Lower Than National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Kentucky, On Par With National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Kansas, On Par With National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Iowa, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Indiana, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Hawaii, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Georgia, Remain Lower Than National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Florida, On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Delaware, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Connecticut, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Colorado, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in California, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Arkansas, Remain Lower Than National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Arizona, On Par With National Costs (Business Wire)
11:00AM	Long-Term Care Costs Increase in Alaska, Exceeding National Costs (Business Wire)
11:00AM	Long-Term Care Costs in Virginia On Par with National Costs (Business Wire)
11:00AM	Long-Term Care Costs in Idaho On Par with National Costs (Business Wire)
09:30AM	Genworth and CareScout Release Cost of Care Survey Results for 2024 (Business Wire)
Feb-20-25 02:07AM	Genworth Financial Inc (GNW) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
02:07AM	Q4 2024 Genworth Financial Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 12:30PM	Genworth Financial (GNW) Q4 2024 Earnings Call Transcript (Motley Fool) -7.92%
Feb-18-25 05:04PM	Genworth Financial: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Genworth Financial Announces Fourth Quarter 2024 Results (Business Wire)
Jan-09-25 04:15PM	Genworth Financial Schedules Earnings Conference Call for February 19 (Business Wire)
02:45PM	Is Genworth Financial (GNW) the Best Single Digit Stock to Buy Now? (Insider Monkey)
Dec-12-24 03:32PM	6 Things to Know About Long-Term Care, From Financial Advisors (Barrons.com)
Dec-10-24 08:53AM	Heres What is Included in Seven Corners Capitals Long Thesis for Genworth Financial (GNW) (Insider Monkey)
Nov-08-24 10:01AM	Genworth Financial Inc (GNW) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... (GuruFocus.com)
Nov-07-24 05:00PM	Genworth Financial (GNW) Q3 2024 Earnings Call Transcript (Motley Fool)
Nov-06-24 06:28PM	Genworth Financial Announces Third Quarter 2024 Results (Business Wire) +8.84%
06:10PM	Genworth Financial: Q3 Earnings Snapshot (Associated Press Finance)
Oct-25-24 07:02PM	Donald Smith & Co. Increases Stake in Genworth Financial Inc. (GuruFocus.com)
Oct-20-24 02:55PM	Is Genworth Financial Inc. (GNW) the Best US Stock to Buy Under $10? (Insider Monkey)
Oct-10-24 04:15PM	Genworth Financial Schedules Earnings Conference Call for November 7 (Business Wire)

Genworth Financial, Inc. engages in offering mortgage and long-term care insurance products. It operates through the following segments: Enact, Long-Term Care Insurance, Life and Annuities, and Corporate and Other. The Enact segment refers to Enact Holdings that offer private mortgage insurance products. The Long-Term Care Insurance segment offers long-term care insurance products in the United States. The Life and Annuities segment focuses on protection and retirement income products. The Corporate and Other segment includes debt financing expenses. The company was founded in 1871 and is headquartered in Glen Allen, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McInerney Thomas J	President and CEO; Director	Dec 02 '25	Sale	8.64	40,000	345,600	5,107,444	Dec 04 04:15 PM
McInerney Thomas J	Officer	Dec 02 '25	Proposed Sale	8.64	40,000	345,600		Dec 02 10:53 AM
Karawan Gregory S.	EVP and General Counsel	Nov 24 '25	Sale	8.51	40,000	340,404	302,000	Nov 25 04:16 PM
Karawan Gregory S.	Officer	Nov 24 '25	Proposed Sale	8.51	40,000	340,403		Nov 24 10:17 AM
Gupta Rohit	President & CEO, Enact	Aug 27 '25	Sale	8.68	86,406	749,866	794,630	Aug 29 04:16 PM

Open in Screener

PBYI

Puma Biotechnology Inc

Feb 17 • 04:00PM ET

6.75

-0.07 -1.03 %

Healthcare • Biotechnology • USA • NASD

PBYI Puma Biotechnology Inc daily Stock Chart

Peers: INCY MRNA EXEL SRPT BPMC KYNB NKTR KPTI LGND AFMD

| Held by: AVUV VTI IWM VXF IWN VTWO BSVO DFAS FESM DFAT

Index	RUT	P/E	9.11	EPS (ttm)	0.74	Insider Own	24.09%	Shs Outstand	50.38M	Perf Week	-1.89%
Market Cap	340.14M	Forward P/E	16.88	EPS next Y	0.40	Insider Trans	-0.61%	Shs Float	38.25M	Perf Month	5.80%
Enterprise Value	284.71M	PEG	-	EPS next Q	0.19	Inst Own	61.80%	Short Float	9.10%	Perf Quarter	36.36%
Income	36.98M	P/S	1.60	EPS this Y	-11.29%	Inst Trans	5.47%	Short Ratio	8.62	Perf Half Y	17.80%
Sales	212.00M	P/B	2.95	EPS next Y	-27.27%	ROA	17.46%	Short Interest	3.48M	Perf YTD	13.45%
Book/sh	2.29	P/C	3.53	EPS next 5Y	-5.09%	ROE	39.69%	52W High	7.28 -7.34%	Perf Year	136.01%
Cash/sh	1.91	P/FCF	7.93	EPS past 3/5Y	- -	ROIC	30.78%	52W Low	2.58 162.14%	Perf 3Y	54.82%
Dividend Est.	-	EV/EBITDA	6.37	Sales past 3/5Y	-3.08% -3.28%	Gross Margin	76.91%	Volatility	4.98% 5.09%	Perf 5Y	-43.84%
Dividend TTM	-	EV/Sales	1.34	EPS Y/Y TTM	56.02%	Oper. Margin	15.83%	ATR (14)	0.31	Perf 10Y	-84.87%
Dividend Ex-Date	-	Quick Ratio	1.62	Sales Y/Y TTM	-12.96%	Profit Margin	17.44%	RSI (14)	55.35	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.74	EPS Q/Q	-57.99%	SMA20	0.56%	Beta	1.22	Target Price	5.00
Payout	0.00%	Debt/Eq	0.36	Sales Q/Q	-32.36%	SMA50	8.58%	Rel Volume	1.03	Prev Close	6.82
Employees	172	LT Debt/Eq	0.04	Earnings	Feb 26 AMC	SMA200	42.20%	Avg Volume	403.72K	Price	6.75
IPO	Apr 20, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	277.78% 1.76%	Trades		Volume	415,277	Change	-1.03%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-28-21	Upgrade	Citigroup	Neutral → Buy	$11
Jun-25-20	Resumed	BofA/Merrill	Underperform	$9
Oct-08-19	Downgrade	Goldman	Neutral → Sell	$24 → $8
May-10-19	Downgrade	Citigroup	Buy → Neutral	$24
May-10-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$57 → $20
Jan-17-19	Initiated	Leerink Partners	Mkt Perform	$21
Jan-03-19	Downgrade	Guggenheim	Buy → Neutral
Nov-19-18	Upgrade	Goldman	Sell → Neutral
Nov-02-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-02-18	Downgrade	BofA/Merrill	Buy → Underperform
Oct-01-18	Initiated	Cantor Fitzgerald	Overweight	$75
Sep-17-18	Initiated	Goldman	Sell	$42
May-11-18	Reiterated	Stifel	Buy	$95 → $87
Nov-10-17	Reiterated	RBC Capital Mkts	Sector Perform	$92 → $108
Nov-10-17	Reiterated	Citigroup	Buy	$156 → $164
Oct-02-17	Reiterated	Stifel	Buy	$110 → $130
Sep-11-17	Reiterated	Credit Suisse	Outperform	$118 → $136
Jul-10-17	Resumed	Leerink Partners	Outperform	$115
Jun-06-17	Reiterated	RBC Capital Mkts	Sector Perform	$60 → $88
May-25-17	Reiterated	RBC Capital Mkts	Sector Perform	$40 → $60

Show Previous Ratings

Feb-12-26 04:07PM	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-10-26 05:25PM	Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-04-26 05:05PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-07-26 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-31-25 11:20AM	Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? (Barchart)
04:10PM	Loading…
Dec-22-25 04:10PM	Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) (Business Wire)
Dec-17-25 11:26AM	CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? (Zacks)
Dec-02-25 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.57%
Nov-27-25 11:58AM	IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? (Zacks)
Nov-07-25 05:05PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +22.24% -21.04%
10:53AM	PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised (Zacks)
12:03AM	Puma Biotechnology Inc (PBYI) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Royalty ... (GuruFocus.com)
Nov-06-25 06:00PM	Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates (Zacks)
04:55PM	Puma Biotech: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports Third Quarter 2025 Financial Results (Business Wire)
05:20PM	Loading…
Nov-05-25 05:20PM	Acadia Pharmaceuticals (ACAD) Q3 Earnings and Revenues Top Estimates (Zacks)
Oct-23-25 04:10PM	Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results (Business Wire)
Oct-09-25 05:06AM	CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains? (Zacks)
Oct-02-25 05:21PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-17-25 02:27PM	What Do Analysts Think About Puma Biotechnology (PBYI)? (Insider Monkey)
Sep-15-25 12:42PM	PBYI Surges 30% in 3 Months: How Should You Play the Stock? (Zacks)
Sep-04-25 05:25PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-02-25 04:07PM	Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference (Business Wire)
Sep-01-25 09:55AM	Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Aug-28-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Aug-13-25 09:15AM	Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue? (Zacks) +8.83%
Aug-12-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
09:15AM	Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out? (Zacks)
09:11AM	Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT (Insider Monkey)
Aug-08-25 05:00PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +12.16% +31.44%
10:26AM	Loading…
10:26AM	PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues (Zacks)
Aug-07-25 05:55PM	Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:56PM	Puma Biotech: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports Second Quarter Financial Results (Business Wire)
Aug-06-25 06:05PM	Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-24-25 04:15PM	Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results (Business Wire)
Jul-15-25 08:31AM	Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns (Zacks)
Jul-14-25 09:40AM	Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? (Zacks)
Jul-10-25 08:50AM	Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors (Zacks)
Jul-08-25 10:31AM	Bayer Begins Phase I/II Study on Cell Therapy for Eye Disease (Zacks)
Jul-04-25 08:35AM	AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer (Zacks)
Jul-02-25 05:03PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:34AM	Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek (Zacks)
Jul-01-25 11:55AM	RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance (Zacks)
10:05AM	ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B (Zacks)
Jun-30-25 10:40AM	Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why (Zacks)
Jun-27-25 10:58AM	PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal (Zacks)
09:40AM	Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? (Zacks)
Jun-25-25 11:30AM	NKTR Stock Soars as Lead Drug Meets Goal in Atopic Dermatitis Study (Zacks)
Jun-24-25 08:50AM	Fast-paced Momentum Stock Puma Biotech (PBYI) Is Still Trading at a Bargain (Zacks)
Jun-19-25 11:11AM	Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma (Zacks)
Jun-18-25 10:51AM	Bayer Seeks FDA Approval for MRI Contrast Agent Gadoquatrane (Zacks)
Jun-12-25 11:30AM	Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report? (Zacks)
Jun-11-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Jun-04-25 05:33PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +7.39%
May-28-25 08:50AM	Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors (Zacks)
May-26-25 09:40AM	Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? (Zacks)
May-12-25 08:50AM	Despite Fast-paced Momentum, Puma Biotech (PBYI) Is Still a Bargain Stock (Zacks)
May-09-25 09:40AM	Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? (Zacks) -5.21%
08:48AM	PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates (Zacks)
03:39AM	Puma Biotechnology Inc (PBYI) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges (GuruFocus.com)
May-08-25 05:55PM	Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates (Zacks)
04:52PM	Puma Biotech: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports First Quarter Financial Results (Business Wire)
May-07-25 05:20PM	Puma Biotechnology Q1 2025 Earnings Preview (Seeking Alpha)
01:25PM	Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y (Zacks)
11:55AM	JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook (Zacks)
08:10AM	Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-06-25 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-05-25 09:15AM	ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? (Zacks)
May-01-25 08:05AM	Biogen Inc. (BIIB) Q1 Earnings Lag Estimates (Zacks)
Apr-30-25 12:00PM	Puma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
06:00AM	Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX (neratinib) for Breast Cancer Patients (GlobeNewswire)
Apr-28-25 03:03PM	Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 (Business Wire)
Apr-24-25 04:11PM	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results (Business Wire)
Apr-23-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Apr-21-25 09:13AM	Is the Options Market Predicting a Spike in Puma Biotechnology Stock? (Zacks)
Apr-11-25 01:20PM	Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential (Seeking Alpha)
Apr-02-25 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-26-25 09:00AM	Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 (Business Wire)
Mar-20-25 12:23PM	Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why (Zacks)
Mar-18-25 04:35AM	Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now (Insider Monkey)
Mar-05-25 06:05PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
05:30PM	Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference (Business Wire)
Mar-03-25 09:40AM	Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? (Zacks) -6.42%
Feb-28-25 12:04PM	Q4 2024 Puma Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents) +19.73%
02:34AM	Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
Feb-27-25 05:29PM	Puma Biotech: Q4 Earnings Snapshot (Associated Press Finance) +7.94%
04:05PM	Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-26-25 04:15PM	Puma Biotechnology to Present at TD Cowens 45th Annual Health Care Conference (Business Wire)
Feb-13-25 04:15PM	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-05-25 05:05PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-03-25 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.45% +20.34%
Jan-01-25 09:40AM	Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? (Zacks)
Dec-23-24 09:01AM	Puma Biotechnologys NERLYNX Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation (Business Wire)
Dec-04-24 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-28-24 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Nov-21-24 05:38AM	Puma commences Phase II trial of alisertib for breast cancer treatment (Clinical Trials Arena)
Nov-20-24 08:57AM	Puma Biotechnology Announces Initiation of ALISCA-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer (Business Wire)
Nov-08-24 02:27AM	Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AUERBACH ALAN H	President and CEO	Jan 07 '26	Sale	5.88	18,012	105,893	7,145,951	Jan 08 08:27 PM
AUERBACH ALAN H	President and CEO	Jan 06 '26	Sale	5.84	16,938	98,986	7,163,963	Jan 08 08:27 PM
HUNT DOUGLAS M	See Remarks	Jan 07 '26	Sale	5.88	5,014	29,477	155,907	Jan 08 08:15 PM
HUNT DOUGLAS M	See Remarks	Jan 06 '26	Sale	5.84	3,973	23,218	160,921	Jan 08 08:15 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jan 07 '26	Sale	5.88	6,405	37,655	193,284	Jan 08 08:14 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jan 06 '26	Sale	5.84	4,540	26,532	199,689	Jan 08 08:14 PM
AUERBACH ALAN H	Officer	Jan 07 '26	Proposed Sale	5.88	18,012	105,893		Jan 07 04:28 PM
HUNT DOUGLAS M	Officer	Jan 07 '26	Proposed Sale	5.88	5,014	29,477		Jan 07 04:25 PM
NOUGUES MAXIMO F	Officer	Jan 07 '26	Proposed Sale	5.88	6,405	37,655		Jan 07 04:24 PM
NOUGUES MAXIMO F	Officer	Jan 06 '26	Proposed Sale	5.84	4,540	26,530		Jan 06 04:53 PM
HUNT DOUGLAS M	Officer	Jan 06 '26	Proposed Sale	5.84	3,973	23,217		Jan 06 04:45 PM
AUERBACH ALAN H	Officer	Jan 06 '26	Proposed Sale	5.84	16,938	98,979		Jan 06 04:44 PM
MILLER MICHAEL PATRICK	Director	Nov 11 '25	Sale	4.86	20,000	97,228	54,000	Nov 13 04:41 PM
MILLER MICHAEL PATRICK	Director	Nov 11 '25	Proposed Sale	4.86	20,000	97,228		Nov 12 08:29 AM
Cesano Alessandra	Director	Jul 18 '25	Sale	3.37	27,000	90,909	41,850	Jul 22 07:51 PM
Cesano Alessandra	Director	Jul 18 '25	Proposed Sale	3.37	27,000	90,909		Jul 18 04:16 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jul 08 '25	Sale	3.53	5,587	19,739	208,164	Jul 10 08:56 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jul 09 '25	Sale	3.54	3,935	13,910	204,229	Jul 10 08:56 PM
HUNT DOUGLAS M	See Remarks	Jul 08 '25	Sale	3.53	4,374	15,453	168,337	Jul 10 08:52 PM
HUNT DOUGLAS M	See Remarks	Jul 09 '25	Sale	3.54	3,443	12,171	164,894	Jul 10 08:52 PM
AUERBACH ALAN H	President and CEO	Jul 08 '25	Sale	3.53	25,592	90,417	7,202,481	Jul 10 08:49 PM
AUERBACH ALAN H	President and CEO	Jul 09 '25	Sale	3.54	21,580	76,285	7,180,901	Jul 10 08:49 PM
NOUGUES MAXIMO F	Officer	Jul 09 '25	Proposed Sale	3.54	3,935	13,910		Jul 09 04:48 PM
AUERBACH ALAN H	Officer	Jul 09 '25	Proposed Sale	3.54	21,580	76,285		Jul 09 04:36 PM
HUNT DOUGLAS M	Officer	Jul 09 '25	Proposed Sale	3.54	3,443	12,171		Jul 09 04:27 PM
AUERBACH ALAN H	Officer	Jul 08 '25	Proposed Sale	3.53	25,592	90,424		Jul 08 04:41 PM
NOUGUES MAXIMO F	Officer	Jul 08 '25	Proposed Sale	3.53	5,587	19,741		Jul 08 04:39 PM
HUNT DOUGLAS M	Officer	Jul 08 '25	Proposed Sale	3.53	4,374	15,455		Jul 08 04:29 PM
WILSON TROY EDWARD	Director	Jun 13 '25	Sale	3.40	10,800	36,720	43,550	Jun 17 07:55 PM
Stuglik Brian M	Director	Jun 13 '25	Sale	3.39	8,100	27,459	94,958	Jun 17 07:52 PM
Senderowicz Adrian	Director	Jun 13 '25	Sale	3.40	27,000	91,800	27,000	Jun 17 07:49 PM
MOYES JAY M	Director	Jun 13 '25	Sale	3.40	22,000	74,800	53,322	Jun 17 07:46 PM
Dorval Allison	Director	Jun 13 '25	Sale	3.40	11,610	39,474	75,390	Jun 17 07:43 PM
Cesano Alessandra	Director	Jun 13 '25	Sale	3.40	12,150	41,310	68,850	Jun 17 07:41 PM
WILSON TROY EDWARD	Director	Jun 13 '25	Proposed Sale	3.40	10,800	36,678		Jun 13 04:15 PM
Senderowicz Adrian	Director	Jun 13 '25	Proposed Sale	3.40	27,000	91,767		Jun 13 04:11 PM
Dorval Allison	Director	Jun 13 '25	Proposed Sale	3.40	11,610	39,437		Jun 13 04:10 PM
Cesano Alessandra	Director	Jun 13 '25	Proposed Sale	3.40	12,150	41,285		Jun 13 04:09 PM
Stuglik Brian M	Director	Jun 13 '25	Proposed Sale	3.39	8,100	27,497		Jun 13 04:07 PM
MOYES JAY M	Director	Jun 13 '25	Proposed Sale	3.40	22,000	74,756		Jun 13 04:04 PM
Ludwig Jeffrey Jerome	Former Officer	May 21 '25	Proposed Sale	3.42	55,882	191,310		May 21 03:00 PM

GNW

Genworth Financial Inc

PBYI

Puma Biotechnology Inc

Upgrade your FINVIZ experience